2019
$225M
from 23 investors over 23 rounds
Delfi Diagnostics raised $225M on July 18, 2022
Investors: PTX Capital, OrbiMed Advisors, -, T. Rowe Price, Osage University Partners (OUP), Samsara BioCapital, Point72 Asset Management, Windham Venture Partners and Point Field Partners
Delfi Diagnostics raised $100M on January 12, 2021
Investors: Foresite Capital, T. Rowe Price, Osage University Partners (OUP), Illumina Ventures, OrbiMed Advisors, Windham Venture Partners, Menlo Ventures, Northpond Ventures and Samsara BioCapital
Delfi Diagnostics raised $5.5M on August 12, 2019
Investors: Menlo Ventures, Samsara BioCapital, Illumina Ventures, AV8 Ventures and Windham Venture Partners